Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces European Patent Granted by EPO: Combination Immunotherapy Approach for Treatment of Cancer
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces FDA Approval for COVID-19 Treatment Manufactured by Partner, Personalized Stem Cells
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces Appointment of Jim Schoeneck, Accomplished Biotech Executive, to Board of Directors
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at AACR 2020 Virtual Annual Meeting II
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi’s Contribution To The Treatment Of COVID-19
In A Short Time, The Novel Coronavirus Disease (COVID-19) Has Destructively Impacted Both The People…
Stem Cells for COVID-19 | PSC Teams Up with Calidi Biotherapeutics
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply…